ArticleFrontiers in immunology2020

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.

Jian-Nan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.